Conductive deafness-ptosis-skeletal anomalies syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Conductive deafness-ptosis-skeletal anomalies syndrome | |
|---|---|
| Synonyms | CDPSAS |
| Pronounce | N/A |
| Specialty | Medical genetics |
| Symptoms | Conductive hearing loss, ptosis, skeletal anomalies |
| Complications | N/A |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history of the condition |
| Diagnosis | Genetic testing, audiometry, physical examination |
| Differential diagnosis | Other syndromes with similar features |
| Prevention | N/A |
| Treatment | Hearing aids, surgical correction of ptosis, orthopedic interventions |
| Medication | N/A |
| Prognosis | Variable, depending on severity of symptoms |
| Frequency | Rare |
| Deaths | N/A |
A rare genetic disorder characterized by hearing loss, drooping eyelids, and skeletal abnormalities
Conductive deafness-ptosis-skeletal anomalies syndrome is a rare genetic disorder that is primarily characterized by a combination of conductive hearing loss, ptosis (drooping of the upper eyelids), and various skeletal anomalies. This syndrome is inherited in an autosomal recessive pattern, meaning that two copies of the mutated gene, one from each parent, are required for an individual to be affected.
Genetic Basis[edit]
Conductive deafness-ptosis-skeletal anomalies syndrome is caused by mutations in a specific gene, although the exact gene responsible has not been definitively identified in all cases. The syndrome follows an autosomal recessive inheritance pattern, which means that both parents of an affected individual are typically carriers of one copy of the mutated gene but do not show symptoms themselves.
Clinical Features[edit]
The clinical presentation of this syndrome includes a triad of symptoms:
Conductive Hearing Loss[edit]
Individuals with this syndrome experience conductive hearing loss, which is due to problems in the middle ear that prevent sound from being conducted efficiently to the inner ear. This type of hearing loss can often be managed with hearing aids or surgical interventions.
Ptosis[edit]
Ptosis refers to the drooping of the upper eyelids, which can affect one or both eyes. This condition can lead to vision problems if severe and may require surgical correction to improve vision and appearance.
Skeletal Anomalies[edit]
The skeletal anomalies associated with this syndrome can vary widely among affected individuals. Common features may include abnormalities in the bones of the hands and feet, short stature, and other skeletal deformities. These anomalies can sometimes lead to functional impairments or require orthopedic interventions.
Diagnosis[edit]
Diagnosis of conductive deafness-ptosis-skeletal anomalies syndrome is based on clinical evaluation, family history, and genetic testing. Audiological assessments are used to confirm the presence of conductive hearing loss, while ophthalmological examinations can assess the severity of ptosis. Genetic testing can help identify mutations in the gene responsible for the syndrome.
Management[edit]
Management of this syndrome is typically multidisciplinary, involving audiologists, ophthalmologists, and orthopedic specialists. Treatment is symptomatic and supportive, focusing on improving hearing, vision, and mobility. Hearing aids or surgical procedures may be used to address hearing loss, while ptosis may be corrected surgically if it interferes with vision. Skeletal anomalies may require orthopedic interventions to improve function and quality of life.
Prognosis[edit]
The prognosis for individuals with conductive deafness-ptosis-skeletal anomalies syndrome varies depending on the severity of the symptoms and the effectiveness of the interventions. With appropriate management, many individuals can lead relatively normal lives, although they may require ongoing medical care and support.
See also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian